Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic.
Ko Un ParkMegan GregoryJoey BazanMaryam LustbergShoshana RosenbergVictoria BlinderPriyanka SharmaLajos PusztaiChengli ShenAnn PartridgeAlastair ThompsonPublished in: Breast cancer research and treatment (2021)
More physicians preferred NET for ER + BC during the pandemic, compared with pre-pandemic times. As the duration of NET extended, more providers favored ALND in low volume metastatic axillary disease. The Covid-19 pandemic affected practice of ER + BC; it remains to be seen how this may impact outcomes.
Keyphrases
- sars cov
- coronavirus disease
- early stage
- lymph node
- primary care
- sentinel lymph node
- estrogen receptor
- endoplasmic reticulum
- breast cancer cells
- rectal cancer
- squamous cell carcinoma
- neoadjuvant chemotherapy
- locally advanced
- small cell lung cancer
- healthcare
- ultrasound guided
- quality improvement
- type diabetes
- stem cells
- young adults
- mesenchymal stem cells
- cell therapy
- insulin resistance
- childhood cancer
- smoking cessation